RAPP
RAPP
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
1
$20.36M
Insider Sales
1
$64K
Total Volume
$20.42M
2 transactions
Net Activity
+$20.29M
Net buying
Sentiment Rating
Moderate AccumulationCEO Conviction Index
Liquidating / Profit Taking
Key Drivers
- •Strong buying bias: purchases represent 100% of total transaction value.
- •CEO selling activity detected. Often driven by option expiration or diversification plans.
- •Ultra-high accumulation: total purchase value exceeds $10M.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
Healy James
Dir
$20.36M total
Ceesay Abraham
CEO
$64K total
Quick Actions
RAPP has an insider buy conviction of 100%, compared to the Unknown sector buy average of 6%. RAPP ranks #89 in insider activity out of 570 tracked companies in its industry.
Over the last 90 days, corporate insiders at RAPP (RAPP) engaged in a total of 2 transactions reported via SEC Form 4 filings. Among these, 1 were open-market purchases and 1 were sales. The total volume of insider trading reached $20.42M.
The net insider activity for RAPP shows a net buying bias of $20.29M. This activity represents a 100% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Purchase by Healy James (Dir), who traded 969.5K shares valued at $20.36M on Oct 28, 2026.
Rapport Therapeutics (Nasdaq:RAPP) - Stock Analysis
Rapport Therapeutics (RAPP) Shares Sink 20% After Hours
RAPP Stock Tempers Premarket Gains On Concerns Over Higher Discontinuation Rates In Bipolar Mania Study
Rapport Therapeutics (RAPP) Shares Sink 20% After Hours
Avoiding Lag: Real-Time Signals in (RAPP) Movement
RAPP - Rapport Therapeutics Inc Stock Price and Quote
FAQs About RAPP Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for RAPP.